4) Medical Countermeasures Initiative
Abstract
The Chem Bio Incident Preparedness and Response-Medical Countermeasures Initiative (CBIPR-MCMI) will integrate advances in regulatory science, formulation and delivery technologies and processes. Also will develop animal models, drug discovery and evaluation of platforms as enablers of the advanced development of CBDP medical countermeasure products. These initiatives will lead to the establishment of multi-use platforms, novel formulations and animal models that can be leveraged during a CBRN response to accelerate medical product development and/or regulatory approval as well as reduce overall development costs.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2024
- Source ID
- d1c8546c94400891ef9b6d2b1c07585d